Inceptor
PrivateLast Round
Series A
Extension
Feb 25, 2025
Total Funding Raised
$84M
Momentum Score
50 /100
Company Overview
Inceptor Bio is a biotechnology company focused on advancing research and developing therapies aimed at curing cancer through the identification, incubation, and acceleration of innovative cell and genetic technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inceptor Comps
Public and private peers based on sector, stage, and business model.
Inceptor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 25, 2025 | ||||
| Series A | May 19, 2022 | ||||
| Seed | Jun 14, 2021 |
Key People
Founding team and executive leadership
Inceptor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kineticos Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 71% MoM, reaching 3.5K.
Inceptor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inceptor's valuation, stock price, and market status.
